The estab lishmentt of Hiroshima human hepatocyte bank
The estab lishmentt of Hiroshima human hepatocyte bank
批准号:
18590493
负责人:
AMANO Hironobu
金额:
$2.46万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Japanese hepatocytes are strongly required for research on development of a new medicine, because there are differences in drug metabolism among not only animal species but also human races. However there are many issues to be discussed such as protection of personal information and bioethics. In 1998, we started research on human hepatocytes isolated from a resected liver of patients with non-viral metastatic liver tumor aiming at regenerative medicine such as bioartificial liver support system and hepatocyte transplantation. We have established perfusion, cryopreservation, and cultivation system of human hepatocytes. On the basis of the background, we are strongly certain about the necessity of a public human hepatocyte bank for research use. We adopted three important plans. The first is the introduction of two step-informed consent which consists of the comprehensive consent for all patients when they first visit our hospital and the secondary consent for cell bank before the operation. The second is the participation of pathologists who judge if the liver tissue was adequately and safely donated or not. The third is the employment of CRC (clinical research coordinators) who can support mental care of patients (donors), assist researchers and return the research results to society. We provided 7 cases of Japanese human hepatocytes to the public resource bank for research use.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Significance of surgical treatment for patients with hepatocellular carcinoma exceeding milan criteria
超过米兰标准的肝细胞癌患者手术治疗的意义
DOI:
--
发表时间:
2008
期刊:
影响因子:
--
作者:
[H., Amano, T., Itamoto, Y., Tanimoto, I., Ushitora, H., Ohdan, H., Tashiro, T., Asahara, Amano Hironobu, Amano Hironobu]
通讯作者:
Amano Hironobu
Risk factors of surgical site infection after heptectomy for hepatocellular carcinoma
肝细胞癌肝切除术后手术部位感染的危险因素
DOI:
--
发表时间:
2007
期刊:
影响因子:
--
作者:
[H., Amano, R., Man, T., Itamoto, Y., Tanimoto, I., Ushitora, A., Oshita, H., Ohdan, H., Tashiro, T., Asahara]
通讯作者:
Asahara
肝内胆管癌に対する外科的治療成績と治療方針
肝内胆管癌的手术治疗结果及治疗策略
DOI:
--
发表时间:
2007
期刊:
影响因子:
--
作者:
[H., Amano, T., Itamoto, A., Oshita, K., Ishiyama, H., Ohdan, H., Tashiro, T., Asahara, 天野尋暢]
通讯作者:
天野尋暢
DOI:
10.1002/jso.20661
发表时间:
2007-03-15
期刊:
JOURNAL OF SURGICAL ONCOLOGY
影响因子:
2.5
作者:
[Oishi, Koichi, Itamoto, Toshiyuki, Asahara, Toshimasa]
通讯作者:
Asahara, Toshimasa
肝炎、肝硬変
肝炎、肝硬化
DOI:
--
发表时间:
2007
期刊:
消化器外科NURSING 12
影响因子:
--
作者:
[古川裕行編, 中島 和江, K. Oishi, T.Itamoto, 板本敏行]
通讯作者:
板本敏行
共 22 条
The new strategy of NK cell therapy with death receptors for the patients with chollangiocellular carcinoma or mixed liver cancer
-
批准号:22591505
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.0万
-
财政年份:2010
-
负责人:AMANO Hironobu
-
依托单位: